Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine + Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + Placebo
Phase 3Completed 0 watching 0 views this week๐ Rising
74
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 24
Phase 35
ApprovedIndication / Disease
Common Cold
Conditions
Common Cold, Pharyngitis
Trial Timeline
Dec 23, 2005 โ May 14, 2007
NCT ID
NCT01062360About Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine + Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + Placebo
Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine + Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + Placebo is a phase 3 stage product being developed by Bayer for Common Cold. The current trial status is completed. This product is registered under clinical trial identifier NCT01062360. Target conditions include Common Cold, Pharyngitis.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01062360 | Phase 3 | Completed |
Competing Products
20 competing products in Common Cold